Diagnosis and treatment of ventilator-associated pneumonia - Impact on survival: A decision analysis

Chest

Volumn 110, Issue 4, 1996, Pages 1025-1034

  Sterling, Timothy R ^a,c   Ho, Edward J ^a   Brehm, Walter T ^a   Kirkpatrick, Michael B ^b  

^a USAF Medical Center Keesler   (United States)

^b UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

antibiotic resistance; bronchoscopic protected specimen brush; decision analysis; nonbronchscopic protected (mini) bronchoalveolar; ventilator associated pneumonia

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAM ANTIBIOTIC;

ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL PNEUMONIA; BRONCHOSCOPY; CLINICAL ARTICLE; HUMAN; INFECTION RISK; PRIORITY JOURNAL;

EID: 0029859905     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.110.4.1025     Document Type: Article

References (51)

1. Pingleton SK, Fagon JY, Leeper KV. Patient selection for clinical investigation of ventilator-associated pneumonia: criteria for evaluating diagnostic techniques. Chest 1992; 102:553S-58S
2. Craven DE, Kunches LM, Kilinsky V, et al. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 1986; 133:792-96
3. Torres A, Aznar R, Gatell JM, et al. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 1990; 142:523-28
4. Fagon JY, Chastre J, Domart Y, et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation: prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am Rev Respir Dis 1989; 139:877-84
5. Fagon JY, Chastre J, Hance AJ, et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993; 94:281-88
6. Rello J, Quintana E, Ausina V, et al. Incidence, etiology, and outcome of nosocomial pneumonia in mechanically ventilated patients. Chest 1991; 100:439-44
7. Kollef MH. Ventilator-associated pneumonia: a multivariate analysis. JAMA 1993; 270:1965-70
8. Rello J, Ausina V, Ricart M, et al. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest 1993; 104:1230-35
9. Fagon JY, Chastre J, Hance AJ, et al. Evaluation of clinical judgment in the identification and treatment of nosocomial pneumonia in ventilated patients. Chest 1993; 103:547-53
10. Langer M, Mosconi P, Cigada M, et al. Long-term respiratory support and risk of pneumonia in critically ill patients. Am Rev Respir Dis 1989; 140:302-05
11. Stevens RM, Teres D, Skillman JJ, et al. Pneumonia in an intensive care unit. Arch Intern Med 1974; 134:106-11
12. Celis R, Torres A, Gatell JM, et al. Nosocomial pneumonia: a multivariate analysis of risk and prognosis. Chest 1988; 93:318-24
13. Seidenfeld JJ, Pohl DF, Bell RC, et al. Incidence, site, and outcome of infections in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1986; 134:12-6
14. Kollef MH. The role of selective digestive tract decontamination on mortality and respiratory tract infections: a meta-analysis. Chest 1994; 105:1101-08
15. Prud'hom G, Leuenberger P, Koerfer J, et al. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer: a randomized controlled trial. Ann Intern Med 1994; 120:653-62
16. Weinstein MC, Fineberg HV. Clinical decision analysis. Philadelphia: WB Saunders, 1980
17. Pauker SG, Kassirer JP. Decision analysis. N Engl J Med 1987; 316:250-58
18. Niederman MS, Torres A, Summer W. Invasive diagnostic testing is not needed routinely to manage suspected ventilator-associated pneumonia. Am J Respir Crit Care Med 1994; 150:565-69
19. Chastre J, Fagon JY. Invasive diagnostic testing should be routinely used to manage ventilated patients with suspected pneumonia. Am J Respir Crit Care Med 1994; 150:570-74
20. Sonnenberg FA, Pauker SG. Decision maker version 7.0. Boston: New England Medical Center, 1993
21. Johanson WG Jr, Pierce AK, Sanford JP, et al. Nosocomial respiratory infections with Gram-negative bacilli: the significance of colonization of the respiratory tract. Ann Intern Med 1972; 77:701-06
22. Wunderink RG, Woldenberg LS, Zeiss J, et al. The radiologic diagnosis of autopsy-proven ventilator-associated pneumonia. Chest 1992; 101:458-63
23. Bell RC, Coalson JJ, Smith JB, et al. Multiple organ system failure and infection in adult respiratory distress syndrome. Ann Intern Med 1983; 99:293-98
24. Fagon JY, Chastre J, Hance AJ, et al. Detection of nosocomial lung infection in ventilated patients: use of protected specimen brush and quantitative culture techniques in 147 patients. Am Rev Respir Dis 1988; 138:110-16
25. Chastre J, Fagon JY, Soler P, et al. Diagnosis of nosocomial bacterial pneumonia in intubated patients undergoing ventilation: comparison of the usefulness of bronchoalveolar lavage and the protected specimen brush. Am J Med 1988; 85:499-506
26. Chastre J, Fagon JY, Soler P, et al. Quantification of BAL cells containing intracellular bacteria rapidly identifies ventilated patients with nosocomial pneumonia. Chest 1989; 95:190S-92S
27. Kirkpatrick MB, Bass JB Jr. Quantitative bacterial cultures of bronchoalveolar lavage fluids and protected brush catheter specimens from normal subjects. Am Rev Respir Dis 1989; 139:546-48
28. Chastre J, Viau F, Brun P, et al. Prospective evaluation of the protected specimen brush for the diagnosis of pulmonary infections in ventilated patients. Am Rev Respir Dis 1984; 130:924-29
29. Meduri GU, Chastre J. The standardization of bronchoscopic techniques for ventilator-associated pneumonia. Chest 1992; 102:557S-64S
30. Chastre J, Fagon JY, Bornet-Lecso M, et al. Evaluation of bronchoscopic techniques for the diagnosis of nosocomial pneumonia. Am J Respir Crit Care Med 1995; 152:231-40
31. Torres A, Martos A, de la Bellacasa JP, et al. Specificity of endotracheal aspiration, protected specimen brush, and bronchoalveolar lavage in mechanically ventilated patients. Am Rev Respir Dis 1993; 147:952-57
32. Torres A, de la Bellacasa JP, Xaubet A, et al. Diagnostic value of quantitative cultures of bronchoalveolar lavage and telescoping plugged catheters in mechanically ventilated patients with bacterial pneumonia. Am Rev Respir Dis 1989; 140:306-10
33. Rouby JJ, de Lassale EM, Poete P, et al. Nosocomial bronchopneumonia in the critically ill: histologic and bacteriologic aspects. Am Rev Respir Dis 1992; 146:1059-66
34. Papazian L, Thomas P, Garbe L, et al. Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia. Am J Respir Crit Care Med 1995; 152:1982-91
35. Rouby JJ, Rossignon MD, Nicolas MH, et al. A prospective study of protected bronchoalveolar lavage in the diagnosis of nosocomial pneumonia. Anesthesiology 1989; 71:679-85
36. Rudolph AH, Prince EV. Penicillin reactions among patients in venereal disease clinics. JAMA 1973; 223:499-501
37. Idsoe O, Guthe T, Willcox RR, et al. Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock. Bull WHO 1968; 38:159-88
38. Gilbert DN. Aminoglycosides. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995; 292
39. Appel GB. Aminoglycoside nephrotoxicity. Am J Med 1990; 88(suppl C):16S-20S
40. Tilghman RC, Finland M. Clinical significance of bacteremia in pneumococcic pneumonia. Arch Intern Med 1937; 59:602-19
41. Finland M. Treatment of pneumonia and other serious infections. N Engl J Med 1960; 263:207-21
42. Silver DR, Cohen IL, Weinberg PF. Recurrent Pseudomonas aeruginosa pneumonia in an intensive care unit. Chest 1992; 101:194-98
43. Leu HS, Kaiser DL, Mori M, et al. Hospital-acquired pneumonia: attributable mortality and morbidity. Am J Epidemiol 1989; 129:1258-67
44. Ruiz-Santana S, Jimenez AG, Esteban A, et al. ICU pneumonias: a multi-institutional study. Crit Care Med 1987; 15:930-32
45. Montravers P, Fagon JY, Chastre J, et al. Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia. Am Rev Respir Dis 1993; 147:38-44
46. Sanders WE Jr, Sanders CC. Inducible beta-lactamases: clinical and epidemiologic implications for use of newer cephalosporins. Rev Infect Dis 1988; 10:830-38
47. Fink MP, Snydman DR, Niederman MS, et al. Treatment of severe pneumonia in hospitalized patients: results of a multicenter randomized, double-blind trial comparing intravenous ciprofloxacin with imipenam/cilastatin. Antimicrob Agents Chemother 1994; 38:547-57
48. Salata RA, Lederman MM, Shlaes DM, et al. Diagnosis of nosocomial pneumonia in intubated, intensive care unit patients. Am Rev Respir Dis 1987; 135:426-32
49. Papazian L, Colt HG, Seemama F, et al. Effects of consecutive protected specimen brushing and bronchoalveolar lavage on gas exchange and hemodynamics in ventilated patients. Chest 1993; 104:1548-52
50. Guerra LF, Baughman RP. Use of bronchoalveolar lavage to diagnose bacterial pneumonia in mechanically ventilated patients. Crit Care Med 1990; 18:169-73
51. Lambert RS, Vereen LE, George RB. Comparison of tracheal aspirates and protected brush catheter specimens for identifying pathogenic bacteria in mechanicallly ventilated patients. Am J Med Sci 1989; 297:377-82